Sfe Investment Counsel buys $8,768,880 stake in HCP (HCP)

HCP (HCP) : Sfe Investment Counsel scooped up 25,390 additional shares in HCP during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 9, 2016. The investment management firm now holds a total of 256,400 shares of HCP which is valued at $8,768,880.HCP makes up approximately 4.08% of Sfe Investment Counsel’s portfolio.

Other Hedge Funds, Including , Financial Architects Inc added HCP to its portfolio by purchasing 1,431 company shares during the most recent quarter which is valued at $48,940. HCP makes up approx 0.02% of Financial Architects Inc’s portfolio.Intersect Capital boosted its stake in HCP in the latest quarter, The investment management firm added 2,514 additional shares and now holds a total of 37,217 shares of HCP which is valued at $1,285,847. HCP makes up approx 0.81% of Intersect Capital’s portfolio. American Century Companies Inc sold out all of its stake in HCP during the most recent quarter. The investment firm sold 103,506 shares of HCP which is valued $3,576,132.

HCP closed down -0.04 points or -0.12% at $34.2 with 26,07,284 shares getting traded on Friday. Post opening the session at $34.12, the shares hit an intraday low of $33.89 and an intraday high of $34.27 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, HCP reported $0.69 EPS for the quarter, based on the information available during the earnings call on May 9, 2016. Analyst had a consensus estimate of $0.69. The company had revenue of $640.80 million for the quarter, compared to analysts expectations of $613.89 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. HCP was Upgraded by Jefferies to ” Hold” on May 10, 2016. UBS Downgraded HCP on Mar 16, 2016 to ” Neutral”, Price Target of the shares are set at $31.Shares were Reiterated by Barclays on Mar 10, 2016 to “Underweight” and Lowered the Price Target to $ 33 from a previous price target of $37 .

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Leave a Reply

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.